Novonesis’ Probiotic for Women’s Health Approved by Health Canada

Novonesis recently announced that its probiotic solution, Astarte, was approved by Health Canada. The probiotic is designed to support both gut and vaginal health in women.

“We work hard to advance women’s health, and we know that women in Canada seek products that are not only natural and effective, but also backed by science and regulatory validation,” said Linda Neckmar, senior vice president of human health biosolutions at Novonesis. “The authorization of Astarte is therefore an important milestone because it gives women confidence that our solution meets the highest standards of safety, quality, and efficacy.”

The approved health claims include:

• Helps support intestinal/gastrointestinal health
• Source of probiotics
• Could promote a favorable gut flora
• Could promote a favorable vaginal flora
• Helps support vaginal health
• Helps support a healthy vaginal flora
• Helps support gastrointestinal and vaginal health
• Helps naturally maintain/promote feminine health
• Helps/supports gastrointestinal health

Clinically Documented Probiotic Strains

The Astarte formula combines four of the most prevalent Lactobacillus species found in the vaginal microbiota of healthy women. Clinical studies demonstrate that supplementation with Astarte is associated with improved vaginal comfort, increased lactobacilli abundance, and maintaining optimal yeast levels.  

“Astarte is a targeted, effective solution for women’s health across all ages, and this authorization opens new opportunities for us to work with our partners to advance women’s health,” said Anne Karina Riise, commercial industry manager of human health biosolutions at Novonesis. “We will build on this and continue our work to bring science-backed innovation to more people, in more markets, and with greater impact.”